Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
Search
Home
Categories
DMD
Research
Press Releases
Approved Treatments
Editorials
Family Stories
Cures
WhatsApp Channel
About Us
Contact
More
Search
Home
Tags
GNT0004
GNT0004
Press Releases
Genethon Reports Results of GNT0004 Gene Therapy Clinical Trial: Permanent Decrease in CK Levels of More Than 75%
Press Releases
Genethon CEO Frederic Revah Announces GNT0004 Gene Therapy Will Provide Amazing Results for DMD (Duchenne Muscular Dystrophy)
Research
Everything You Should Know About Genethon’s Gene Therapy GNT0004 for Duchenne Muscular Dystrophy
Popular
Frequently Asked Questions About Elevidys Used for Duchenne Muscular Dystrophy
DMD Warrior
-
December 26, 2024
Must Read
DMD
Micro Dystrophin: 5 Critical Questions Everyone Is Thinking About
Press Releases
SonoThera Ultrasound-Mediated Delivery Method Can Deliver Full-Length Dystrophin to Cells
Press Releases
Scribe Therapeutics and Prevail Therapeutics to Share In Vivo CRISPR-based Genome Editing Data at ASGCT 2025